Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19
Clinical trial NCT05689827 · COMPLETED
Trial details
- NCT number
- NCT05689827
- Sponsor
- Promomed, LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2022-11-10
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.